01.11.2000 | ORIGINAL PAPER
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 12/2000
Einloggen, um Zugang zu erhalten